Welcome to our dedicated page for Addus Homecare SEC filings (Ticker: ADUS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Addus HomeCare Corp. (NASDAQ: ADUS) SEC filings page on Stock Titan brings together the company’s regulatory disclosures from the U.S. Securities and Exchange Commission, with AI-powered tools to help interpret the information. Addus HomeCare is a Delaware corporation based in Frisco, Texas that provides personal care, hospice and home health services, and its filings offer detailed insight into this business.
Investors can use this page to access periodic and current reports where the company discusses its operations, financial condition and governance. Form 8-K filings, for example, are used by Addus HomeCare to report events such as quarterly earnings announcements, annual meeting voting results and acquisition-related updates. Recent 8-K and 8-K/A filings describe the company’s results of operations for specific quarters, the completion and financial reporting of the Gentiva personal care acquisition and the outcomes of its 2025 annual meeting of stockholders.
Annual reports on Form 10-K and quarterly reports on Form 10-Q (when available through EDGAR) typically contain segment information for personal care, hospice and home health, along with discussions of payor mix, reimbursement exposure and risk factors. For a home health care services company like Addus HomeCare, these filings are central to understanding how government programs, managed care organizations and other payors affect revenue.
On Stock Titan, AI-generated summaries are designed to highlight key points from lengthy filings, such as changes in segment performance, updates on acquisitions, or governance decisions disclosed in proxy-related materials. Users can also review exhibits referenced in 8-K filings, including earnings press releases that are incorporated by reference. This page further facilitates monitoring of executive and director matters disclosed in meeting results and other governance-related filings.
By combining real-time EDGAR updates with AI explanations, the Addus HomeCare SEC filings page helps readers navigate complex regulatory documents, from 10-K and 10-Q reports to 8-K and 8-K/A filings, and understand how these disclosures relate to the company’s home-based care operations.
Addus HomeCare Corp. (ADUS) submitted a Form 144 disclosing a proposed sale of 25,000 common shares through Morgan Stanley Smith Barney LLC, scheduled for 08/20/2025. The filing shows the shares were acquired and paid for on 08/20/2025 via a stock option exercise with cash payment. The aggregate market value of the shares at filing is $2,873,862.50 and the company reports 18,407,239 shares outstanding. The filer reports no sales of the issuer’s securities in the past three months and includes the standard Rule 144 representation regarding possession of material nonpublic information.
Addus HomeCare Corp. (ADUS) filing a Form 144 notifies the proposed sale of 1,571 common shares through Morgan Stanley Smith Barney, with an aggregate market value of $180,555.03 and an approximate sale date of 08/19/2025 on NASDAQ. The filer reports total outstanding shares of 18,407,239. The shares were acquired as restricted stock in three tranches: 1,013 on 06/12/2025, 104 on 06/16/2022, and 454 on 06/15/2021. The filing contains no reported sales in the past three months and includes the standard attestation about material nonpublic information.
Insider sales and a charitable gift reduced the reporting person’s stake in Addus HomeCare (ADUS). The reporting person sold a total of 9,000 shares in two blocks at weighted average prices around $114.18 and $115.49, reducing beneficial ownership from 50,505 shares to 42,505 shares and then to 41,605 shares after a subsequent gift. The filing also discloses a gift of 900 shares to a charitable organization, recorded with zero cash consideration. All transactions are reported as direct holdings.
Addus HomeCare Corp (ADUS) submitted a Form 144 notifying a proposed sale of 9,000 common shares to be executed through Morgan Stanley Smith Barney LLC on NASDAQ approximately 08/13/2025. The filing lists an aggregate market value of $1,038,105.90 and 18,407,239 shares outstanding, implying a per-share value near $115.35 and the sale representing about 0.05% of outstanding shares.
All 9,000 shares were issued as restricted stock across grants dated 03/01/2022, 02/23/2024, 02/24/2024 and 02/24/2025. The filing reports no securities sold in the past three months and includes the seller's certification that they are not aware of undisclosed material adverse information. The document provided does not identify the individual seller or include additional issuer contact details in the visible fields.
Addus HomeCare Corp. Schedule 13G reports that Capital Research Global Investors (CRGI) beneficially owns 1,102,298 shares of common stock, equal to 6.0% of the 18,399,139 shares reported outstanding. CRGI is described as a division of Capital Research and Management Company and related investment management entities and is deemed the beneficial owner through those entities. The filing states CRGI has sole voting power and sole dispositive power over all 1,102,298 shares and no shared powers. The filing certifies the securities are held in the ordinary course of business and not to influence control. SMALLCAP World Fund, Inc. is identified as an account referenced in the filing.
Wasatch Advisors LP reports beneficial ownership of 929,154 shares of Addus HomeCare common stock, representing 5.1% of the class. That level of ownership triggers Schedule 13G/A disclosure and identifies Wasatch as a material institutional holder of Addus HomeCare.
The filing states Wasatch has sole dispositive power over all 929,154 shares and sole voting power over 690,487 shares, with no shared voting or dispositive power. The document classifies Wasatch as an investment adviser organized in Delaware and includes a certification that the securities were acquired and are held in the ordinary course of business and were not acquired to change or influence control of the issuer.
Esteban Lopez, a director of Addus HomeCare (ADUS), sold 522 shares of common stock on 08/08/2025 at $109 per share. After the sale he beneficially owns 4,016 shares held directly. The filing reports only this non-derivative sale, shows no derivative holdings, and does not disclose a 10b5-1 trading plan. The Form 4 was executed by an attorney-in-fact.
Addus HomeCare (ADUS) filed a Form 144 reporting a proposed resale of 522 common shares through Morgan Stanley Smith Barney LLC on NASDAQ, with an aggregate market value of $56,898 and 18,407,239 shares outstanding. The filing lists an approximate sale date of 08/08/2025.
The securities were acquired as restricted stock from the issuer on 06/12/2025 with payment recorded the same day, and the filer reports "Nothing to Report" for sales in the past three months. This Form 144 is a notice of intended resale under Rule 144 and includes the seller's representation that they are not aware of any undisclosed material adverse information.